Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Goodwill (2022 - 2025)

GeneDx Holdings has reported Goodwill over the past 2 years, most recently at $13.5 million for Q4 2025.

  • Quarterly results put Goodwill at $13.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $13.5 million (changed N/A YoY), and the annual figure for FY2025 was $13.5 million, changed.
  • Goodwill for Q4 2025 was $13.5 million at GeneDx Holdings, up from $12.8 million in the prior quarter.
  • Over the last five years, Goodwill for WGSWW hit a ceiling of $181.5 million in Q3 2022 and a floor of $12.8 million in Q3 2025.